Zalunfiban At First Contact Reduced Severe Heart Damage Risk
10 Nov 2025 //
PR NEWSWIRE
Novel Anti-Platelet Drug Phase 3 Study For Heart Attack Shows
23 Sep 2025 //
PR NEWSWIRE
Celecor Finishes Multinational Phase 3 Study of Heart Attack
27 May 2025 //
PR NEWSWIRE

Market Place
Sourcing Support